US2007041964A1PendingUtilityA1

WISP polypeptides and nucleic acids encoding same

Assignee: BOTSTEIN DAVIDPriority: Oct 29, 1997Filed: Jul 17, 2006Published: Feb 22, 2007
Est. expiryOct 29, 2017(expired)· nominal 20-yr term from priority
A61P 7/00A61P 39/00A61P 43/00A61P 9/10A61P 37/02A61P 31/10A61P 35/00A61P 31/04A61P 29/00A61P 35/02A61P 17/00C07K 14/475A61P 15/08A61P 13/12C07K 14/47C07K 2317/74C12Q 1/6886C07K 16/22A61P 19/00C07K 16/18C07K 2317/73C07K 16/30C07K 16/32A61P 17/02C12Q 2600/136
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Wnt-1-Induced Secreted Proteins (WISPs) are provided, whose genes are induced at least by Wnt-1. Also provided are nucleic acid molecules encoding those polypeptides, as well as vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides, and methods for producing the polypeptides.

Claims

exact text as granted — not AI-modified
1 .- 11 . (canceled)  
     
     
         12 . A method for inhibiting the growth of tumor cells comprising exposing a cell that overexpresses a Wnt-1-induced gene to an effective amount of an antagonist that inhibits the expression or activity of a WISP-1 polypeptide.  
     
     
         13 . The method of  claim 12  wherein said antagonist is an antibody specifically binding a WISP-1 polypeptide.  
     
     
         14 . The method of  claim 12  or  claim 13  wherein the tumor cells are colon cancer cells, the antibody is against human WISP-1 and is a humanized or human monoclonal antibody, and the tumor cells are those of a human.

Join the waitlist — get patent alerts

Track US2007041964A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.